2 Minute Read
The pharmaceutical industry faces increasing difficulty accurately calculating and reporting government prices due to stringent regulations and recent complex changes.
3 Minute Read
Explore the best practice recommendations regarding compliance for SPTR.
4 Minute Read
Expert opinions from a recent price transparency congress on reporting, remediation, and ways to manage state price transparency now and in the future.
4 Minute Read
This month we discuss COVID-19 vaccine mandates, the recent HHS drug discount ruling, and Medicare drug price reforms.
4 Minute Read
We discuss the Biden administration's plan for combatting high drug prices, the new PBM public law reporting cycle, and MA and Part D rule for 2022.
3 Minute Read
Examining common questions about the 340B program and what ICyte solutions are available to identify and act on non-compliance.
2 Minute Read
As more states begin to adopt price transparency laws, we examine the latest laws enacted by individual states and what it means for manufacturers.
3 Minute Read
We review how discount cards have disrupted the prescription market as well as updates to the most-favored-nation pricing model and new STPR laws in Maine.
5 Minute Read
Six key elements to operate an effective compliance program. Also, new VA FSS rules for vaccine drugs, State Price Transparency, and Medicare Part D updates and reminders.